Dividend Darling With Upside: Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Dividend Darling With Upside: Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Dividend Darling With Upside: Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

The fund owned 37,134 shares of the pharmacy operator's stock after buying an additional 28,470 shares during the quarter. The Price Range of Walgreens Boots Alliance, Inc. What is market worth of stock?

Drilling down into some additional key near-term indicators we note that the Capex to PPE ratio stands at 0.105564 for Walgreens Boots Alliance, Inc.

Many individuals strive to become successful stock market traders. More interesting news about Walgreens Boots Alliance, Inc. Analyst recommendation for this stock stands at 2.7. Finally, UBS Group assumed coverage on shares of Walgreens Boots Alliance in a research note on Thursday. In terms of Net Debt to EBIT, that ratio stands at 2.38519. Finally, Capital International Investors boosted its position in shares of Walgreens Boots Alliance by 24.4% during the 3rd quarter.

GILD institutional ownership is held at 81.4% while insider ownership was 0.4%.

NASDAQ:WBA opened at $72.43 on Friday. Walgreens Boots Alliance Inc has a 12 month low of $59.07 and a 12 month high of $86.31. The company has market cap of $67.94 billion.

Walgreens Boots Alliance, Inc. has a P/S and P/B values of 0.51 and 2.67 respectively. The pharmacy operator reported $1.46 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $1.43 by $0.03. It has a Return on Investment (ROI) of 3.80% and a gross margin of 65.40%. The firm had revenue of $33.79 billion for the quarter, compared to the consensus estimate of $33.90 billion. It has a RSI value of 47.02. The business's quarterly revenue was up 9.9% compared to the same quarter previous year. (NasdaqGS:WBA) now has one year cash flow growth of 0.00455 1yr Growth Cash Flow = 1 year percentage growth of a company's Cash Flow from operations (Cash Flow Statement).

Our vendor, Zacks Investment Research, hasn't provided us with the upcoming earnings report date. (NASDAQ:WBA) is trading 21.89% away from the stock's 52-week low and -16.58% off of the 52-week high. BidaskClub upgraded shares of Walgreens Boots Alliance from a "buy" rating to a "strong-buy" rating in a report on Friday, September 28th. Beta measures stock's price volatility relative to the market. BKD Wealth Advisors LLC now owns 3,737 shares of the pharmacy operator's stock worth $255,000 after purchasing an additional 681 shares during the last quarter. This means that the stock price might likely increase by 6.32% from its current trading price.8 out of 26 Wall Street analysts which represents 30.77% rated the stock as a buy while the remaining 61.54 rated it as a hold, with 7.69 of analysts rating it as a sell. Several studies suggest that positive earnings surprises not only lead to an immediate hike in a stock's price, but also to a gradual increase over time.

Investors looking to take advantage of cash heavy shares, they might look first to the cash flow of a company, and how fast that is growing. Also, EVP Kathleen Wilson-Thompson sold 52,000 shares of the company's stock in a transaction on Wednesday, October 31st. The shares were sold at an average price of $78.81, for a total transaction of $555,610.50. Following the completion of the sale, the director now directly owns 5,709 shares of the company's stock, valued at $449,926.29.

The stock showed weekly performance of -0.68% and it maintained for the month at -5.55%. (WBA) stock showed the move of 0.29% with the closing price of $72.00. If you are accessing this story on another website, it was illegally stolen and republished in violation of USA & global copyright and trademark law. The original version of this news story can be accessed at https://www.modernreaders.com/news/2019/01/19/meridian-financial-partners-llc-acquires-new-position-in-walgreens-boots-alliance-inc-wba.html.

Walgreens joins Walmart, Kroger and Gap Inc among major retailers to have recently announced partnerships with Microsoft, whose Azure, as Fortune's Adam Lashinsky put it in an article on Tuesday, is at the nexus of Microsoft's "intelligent edge" strategy wherein every product and service aims to strengthen Azure, its growth engine. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

Notícias recomendadas

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.